News

Supriya Lifescience rises on collaborating with Plasma Nutrition Supriya Lifescience is currently trading at Rs. 278.45, up by 3.60 points or 1.31% from its previous closing of Rs. 274.85 on the BSE. The scrip opened at Rs. 281.30 and has touched a high and low of Rs. 287.65 and Rs. 278.85 respectively. So far 29993 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 381.70 on 03-Aug-2022 and a 52 week low of Rs. 170.05 on 27-Mar-2023. Last one week high and low of the scrip stoo...
Supriya Lifescience rises on collaborating with Plasma Nutrition
Supriya Lifescience rises on collaborating with Plasma Nutrition
Source: Accord Fintech
3/08/2023 9:52:37 AM
Supriya Lifescience Ltd and Plasma Nutrition, Inc Announce Groundbreaking Collaboration in Protein Technology Supriya Lifescience Ltd, a prominent Mumbai-based company specializing in active pharmaceutical ingredients (API), proudly announces its recent collaboration with Plasma Nutrition, Inc, a renowned United States-based company known for innovative consumer products located at Delaware. The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience Ltd the sole rights for manufacturing and marketing Ingredient Optimized Protein (ioProtein) in In...
Supriya Lifescience Ltd and Plasma Nutrition, Inc Announce Groundbreaking Collaboration in Protein Technology
Supriya Lifescience Ltd and Plasma Nutrition, Inc Announce Groundbreaking Collaboration in Protein Technology
Source: PR Agency
2/08/2023 5:57:04 PM
Supriya Life gains on securing CEP for anti-histamine therapy Supriya Lifescience rose 1.52% to Rs 300.85 after the company said it received Certification of Suitability for anti-histamine therapy from the European Directorate for the Quality of Medicines and HealthCare. The European Directorate for the Quality of Medicines and HealthCare (EDQM) has granted Certification of Suitability (CEP) to Supriya Lifescience for Diphenhydramine Hydrochloride, an API in anti-histamine therapy. This will be an added advantage for Supriya Lifescience in the Europe...
Supriya Life gains on securing CEP for anti-histamine therapy
Supriya Life gains on securing CEP for anti-histamine therapy
Source: Dion Global Solutions Ltd
29/09/2022 2:41:47 PM
Key News - Visaka Industries Ltd, ITC Ltd, BOC Aviation Ltd, Gokaldas Exports Ltd, Supriya Lifescience Ltd By ARETE Securities Key News ATUM Solar Roof - Designed, Innovated and Made in India - for the World - receives a Patent from USA Visaka Industries Limited has been granted a patent for its product "ATUM" Solar Roof by the United States of America Patent Office, which is valid for 20 years. The patent has been granted for the invention titled "Eco-Friendly Energy Generating Roofs.“ Since its launch in 2018, ATUM Solar Roof has received patents from India (2020), South Africa (2021) and...
Key News - Visaka Industries Ltd, ITC Ltd, BOC Aviation Ltd, Gokaldas Exports Ltd, Supriya Lifescience Ltd By ARETE Securities
Key News - Visaka Industries Ltd, ITC Ltd, BOC Aviation Ltd, Gokaldas Exports Ltd, Supriya Lifescience Ltd By ARETE Securities
Source: ARETE Securities Ltd
29/12/2021 9:30:56 AM
Post listing view on Supriya Lifescience IPO By Mr. Santosh Meena, Swastika Investmart Ltd Below is the Post listing view on Supriya Lifescience IPO by Mr. Santosh Meena, Head of Research, Swastika Investmart Ltd In the last 3-5 years, the API and specialty chemical industry have been darling for investors, and we believe that this trend will continue for several years. As a result of the decent participation from investors, the IPO debuted at Rs 421 versus the issue price of Rs 274, a premium of 53%. In the long run, investors should hold the stock while tho...
Post listing view on Supriya Lifescience IPO By Mr. Santosh Meena, Swastika Investmart Ltd
Post listing view on Supriya Lifescience IPO By Mr. Santosh Meena, Swastika Investmart Ltd
Source: Swastika Investmart Ltd
28/12/2021 12:21:16 PM
Perspective on Supriya Lifescience IPO listing By Ms. Sneha Poddar, Motilal Oswal Financial Services Below is Perspective on Supriya Lifescience IPO listing By Ms. Sneha Poddar, AVP Retail Research, Motilal Oswal Financial Services “Supriya Lifescience, a pharma API manufacturer, made a stellar debut with 55% gains, listing at Rs425/share against IPO price of Rs274, amidst positive market sentiments. It has a niche product portfolio of 38 APIs with focus primarily on diverse therapeutic areas. It has consistently been India’s largest exporter of certain niche pr...
Perspective on Supriya Lifescience IPO listing By Ms. Sneha Poddar, Motilal Oswal Financial Services
Perspective on Supriya Lifescience IPO listing By Ms. Sneha Poddar, Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
28/12/2021 12:18:49 PM
Supriya Lifescience lists with 55.11% premium on the BSE Supriya Lifescience has debuted at Rs 425.00 on the BSE, up by 151 points or 55.11% from its issue price of Rs 274. The scrip is currently trading at Rs 396.90, up by 122.90 points or 44.85% from its issue price. It has touched a high and low of Rs 425.00 and Rs 388.20 respectively. So far 5.67 lakh shares were traded on the counter. The offering, which was open for subscription between December 16, 2021 and December 20, 2021, was subscribed 71.51 times. The issue price was fixed at Rs ...
Supriya Lifescience lists with 55.11% premium on the BSE
Supriya Lifescience lists with 55.11% premium on the BSE
Source: Accord Fintech
28/12/2021 11:01:52 AM
Pre Listing view on Supriya Lifescience IPO By Mr. Aayush Agrawal, Swastika Investmart Ltd Below is the Pre Listing view on Supriya Lifescience IPO By Mr. Aayush Agrawal, Sr. Analyst, Swastika Investmart Ltd Supriya Lifesciences, another good company from the API segment garnered lots of investors' interest on the back of strong financials and attractive valuations. We are expecting a strong listing of this company as market sentiments have improved and the IPO witnessed strong subscription numbers. The grey market is indicating a listing gain of more than 5...
Pre Listing view on Supriya Lifescience IPO By Mr. Aayush Agrawal, Swastika Investmart Ltd
Pre Listing view on Supriya Lifescience IPO By Mr. Aayush Agrawal, Swastika Investmart Ltd
Source: Swastika Investmart Ltd
27/12/2021 5:17:35 PM
Quote on Supriya Lifescience Limited IPO subscribed 3.07 times on Day -2 By Yash Gupta, Angel One Ltd Below is quote on Supriya Lifescience Limited IPO subscribed 3.07 times on Day -2 By Mr. Yash Gupta, Equity Research Analyst, Angel One Ltd    Supriya Lifescience Limited IPO received good response from retail investors, overall IPO subscribed 3.07 times and retail portion subscribed more than 15 times. Non institutional investors (NII) and Qualified institutional buyer (QIB) have not shown much response as of now, we have seen in earl...
Quote on Supriya Lifescience Limited IPO subscribed 3.07 times on Day -2 By Yash Gupta, Angel One Ltd
Quote on Supriya Lifescience Limited IPO subscribed 3.07 times on Day -2 By Yash Gupta, Angel One Ltd
Source: Angel One Ltd
17/12/2021 12:58:15 PM
IPO Note - Supriya Lifescience Ltd By Geojit Financial A Niche player with a Global presence KEY CHANGES: TARGET … Supriya Lifescience Ltd (SSL), incorporated on 26th March 2008, is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (API), focusing on research and development. As of October 31, 2021, SSL has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. SSL is the largest exporter of ...
IPO Note - Supriya Lifescience Ltd By Geojit Financial
IPO Note - Supriya Lifescience Ltd By Geojit Financial
Source: Geojit Financial Services Ltd
17/12/2021 11:15:13 AM
Key News - Hindustan Aeronautics Ltd, Supriya Lifescience Ltd, Larsen & Toubro Ltd, Novartis, Byju's By ARETE Securities Key News HAL signs Rs 2,400 cr contract with BEL for supply of avionics for LCA Hindustan Aeronautics Limited on Thursday awarded a Rs 2,400 crore contract to Bharat Electronics Limited for the manufacture and supply of 20 types of airborne electronic systems for the LCA Tejas Mk1A fighter aircraft programme. The order spanning five years from 2023 to 2028 involves supply of critical avionic Line Replaceable Units (LRUs) related to Digital Flight Control Computers, Air Data Computers, ...
Key News - Hindustan Aeronautics Ltd, Supriya Lifescience Ltd, Larsen & Toubro Ltd, Novartis, Byju's By ARETE Securities
Key News - Hindustan Aeronautics Ltd, Supriya Lifescience Ltd, Larsen & Toubro Ltd, Novartis, Byju's By ARETE Securities
Source: ARETE Securities Ltd
17/12/2021 9:27:23 AM
IPO Note - Supriya Lifescience Ltd By Motilal Oswali Supriya Lifescience Ltd (SLL) is one of the key Indian manufacturers of Pharma APIs, with focus primarily on diverse therapeutic areas. Largest exporter of certain niche products: SLL offers 38 APIs focusing on high value products with limited competition. It has been consistently the largest exporter of Chlorpheniramine Maleate (used in anti-histamine and anti-allergic drug; 45-50% share) and Ketamine Hydrochloride (pain management drug; 60-65% share) from India from FY17-21. It is al...
IPO Note - Supriya Lifescience Ltd By Motilal Oswali
IPO Note - Supriya Lifescience Ltd By Motilal Oswali
Source: Motilal Oswal Financial Services Ltd
16/12/2021 2:01:37 PM
Quote on Supriya Lifescience Limited IPO opens today, We have a Subscribe rating By Yash Gupta, Angel One Ltd Below is quote on Supriya Lifescience Limited IPO opens today, We have a Subscribe rating By Mr. Yash Gupta, Equity Research Analyst, Angel One Ltd    Supriya Lifescience Limited IPO opens today with IPO size of ₹700 crores, company has fixed the IPO price band of ₹265-₹274. IPO opens on 16th December 2021 and closes on 20th December 2021. Supriya Lifescience Limited is one of the key Indian manufacturers and suppliers of active pharmaceutical...
Quote on Supriya Lifescience Limited IPO opens today, We have a Subscribe rating By Yash Gupta, Angel One Ltd
Quote on Supriya Lifescience Limited IPO opens today, We have a Subscribe rating By Yash Gupta, Angel One Ltd
Source: Angel One Ltd
16/12/2021 11:58:40 AM
IPO Note - Supriya Lifesciences Ltd By Nirmal Bang BACKGROUND Supriya Lifesciences Ltd (SLL) is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, the company had niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, antiasthmatic and anti-allergic. It is consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydroch...
IPO Note - Supriya Lifesciences Ltd By Nirmal Bang
IPO Note - Supriya Lifesciences Ltd By Nirmal Bang
Source: Nirmal Bang Ltd
16/12/2021 10:53:08 AM
IPO Note - Supriya Lifescience Limited By Angel One Supriya Lifescience Limited was incorporated in March 2008 by Satish Waman Wagh. Company is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs). Supriya Lifescience Limited focus on research and development along with this company focus is on diverse therapeutic areas and niche products. Company has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti...
IPO Note - Supriya Lifescience Limited By Angel One
IPO Note - Supriya Lifescience Limited By Angel One
Source: Angel One Ltd
15/12/2021 5:26:51 PM
Quote on Supriya Lifescience Limited - Subscribe Rating By Yash Gupta, Angel One Ltd Below is quote on Supriya Lifescience Limited - Subscribe Rating By Mr. Yash Gupta, Equity Research Analyst, Angel One Ltd    Supriya Lifescience Limited was incorporated in March 2008 by Satish Waman Wagh. Company is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs). Supriya Lifescience Limited focus on research and development along with this company focus is on diverse therapeutic areas and niche pr...
Quote on Supriya Lifescience Limited - Subscribe Rating By Yash Gupta, Angel One Ltd
Quote on Supriya Lifescience Limited - Subscribe Rating By Yash Gupta, Angel One Ltd
Source: Angel One Ltd
15/12/2021 5:00:39 PM
IPO Note - Supriya Lifescience Ltd By Choice Broking Salient features of the IPO: * Mumbai-based active pharmaceuticals ingredients (API) manufacturer, Supriya Lifescience Ltd. (SLL), is coming up with an IPO to raise Rs. 700cr, which opens on 16th Dec. and closes on 20th Dec. 2021. The price band is Rs. 265 - 274 per share. * The issue is a combination of fresh and OFS. The company will not receive any proceeds from the OFS part of the issue. From the fresh issue net proceeds, Rs. 92.3cr will be used to fund the proposed expansion o...
IPO Note - Supriya Lifescience Ltd By Choice Broking
IPO Note - Supriya Lifescience Ltd By Choice Broking
Source: Choice Broking
15/12/2021 4:30:30 PM
IPO Report - Supriya Lifescience Ltd By Swastika Investmart Incorporated in 2008, Supriya Lifescience Limited is an Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”). As of October 31, 2021 company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the ...
IPO Report - Supriya Lifescience Ltd By Swastika Investmart
IPO Report - Supriya Lifescience Ltd By Swastika Investmart
Source: Swastika Investmart Ltd
15/12/2021 2:47:05 PM
IPO Note - Supriya Lifescience Ltd By Religare Broking Ltd Supriya Lifescience Ltd About the Company Supriya Lifescience Ltd. (Supriya) is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. It has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. It has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride f...
IPO Note - Supriya Lifescience Ltd By Religare Broking Ltd
IPO Note - Supriya Lifescience Ltd By Religare Broking Ltd
Source: Religare Broking Ltd
15/12/2021 9:55:35 AM
Supriya Lifescience announces launch of initial public offering Supriya Lifescience Ltd. has announced public offering of 25547446 shares at a price of Rs 2.00 each for Cash at a Premium of Rs 272.00 per share. The gross proceeds of the issue are expected to be Rs 70,000.00 lakhs. The company's initial public offer (IPO) will open on 16 December 2021 and is expected to close on 20 December 2021, subject to customary closing conditions. The price band of the issue has been fixed at Rs 265.00-274.00 per share. The IPO includes a fresh Issue of 255...
Supriya Lifescience announces launch of initial public offering
Supriya Lifescience announces launch of initial public offering
Source: Dion Global Solutions Ltd
13/12/2021 1:02:14 PM